Pamnani M B, Rinaudo M S, Haddy F J, Cragoe E J
Department of Physiology, Uniformed Services University, Bethesda, Maryland 20814-4799.
Hypertension. 1988 May;11(5):445-51. doi: 10.1161/01.hyp.11.5.445.
6-Iodoamiloride, an analogue of the sodium channel blocker amiloride, is a vasodilator-depressor, diuretic-natriuretic, and antikaliuretic agent. In these experiments we intravenously infused 6-iodamiloride (0.38 mg/100 g body weight) over a 10- to 11-minute period into rats with reduced renal mass-saline hypertension or one-kidney, one clip hypertension. The infusion produced a prompt but transient fall in blood pressure. These findings are in contrast to those in spontaneously hypertensive rats (SHR), in which the same infusion of 6-iodoamiloride produced a prompt, pronounced, and sustained fall in blood pressure. Studies from a number of laboratories suggest that vascular smooth muscle cells from the SHR have increased permeability to sodium whereas vascular smooth muscle cells from the other two models do not. Thus, 6-iodoamiloride may have potential both as a diagnostic probe and a therapeutic agent for hypertension characterized by increased vascular smooth muscle cell permeability to sodium.
6-碘阿米洛利是钠通道阻滞剂阿米洛利的类似物,是一种血管舒张-降压、利尿-利钠和抗利尿钾剂。在这些实验中,我们在10至11分钟内将6-碘阿米洛利(0.38毫克/100克体重)静脉输注到肾质量减少-盐水性高血压大鼠或单肾单夹高血压大鼠体内。输注导致血压迅速但短暂下降。这些发现与自发性高血压大鼠(SHR)的情况形成对比,在SHR中,相同剂量的6-碘阿米洛利输注会导致血压迅速、显著且持续下降。多个实验室的研究表明,SHR的血管平滑肌细胞对钠的通透性增加,而另外两种模型的血管平滑肌细胞则没有。因此,6-碘阿米洛利可能具有作为诊断探针和治疗以血管平滑肌细胞对钠通透性增加为特征的高血压的治疗剂的潜力。